Dr. Catherine Diefenbach is a hematologist/oncologist specializing in the care of patients with lymphoma. She is director of hematology translational research, and director of the Clinical Lymphoma Program at NYU Langone’s Perlmutter Cancer Center.
She also serves as the principal investigator for numerous clinical trials at NYU Langone involving a range of different therapies, including targeted therapy, immunotherapy, and radiation therapy. Many of these clinical trials are investigating innovative ways to combine new targeted or immune-based therapies with existing therapies to find new ways to control lymphoma.
Dr. Diefenbach received her medical degree from the University Of Pennsylvania, and did her residency in internal medicine at Johns Hopkins Hospital. She has her board certification in hematology from the American Board of Internal Medicine, and in internal medicine from the American Board of Internal Medicine.
